Release of Amino‐ or Carboxy‐Containing Compounds Triggered by HOCl: Application for Imaging and Drug Design
作者:Peng Wei、Lingyan Liu、Ying Wen、Guilong Zhao、Fengfeng Xue、Wei Yuan、Ruohan Li、Yaping Zhong、Mengfan Zhang、Tao Yi
DOI:10.1002/anie.201813648
日期:2019.3.26
a marker of these diseases, HOCl might also be used as an activator of prodrugs or drug delivery systems for the treatment of the corresponding disease. In this work, a new platform of HOCl probes has been developed that integrates detection, imaging, and therapeutic functions. The probes can detect HOCl, using both NIR emission and the naked eye in vitro, with high sensitivity and selectivity at ultralow
HOCl的过量生产与诸如动脉粥样硬化,类风湿性关节炎和癌症的疾病高度相关。HOCl可以作为这些疾病的标志物,也可以用作治疗相应疾病的前药或药物输送系统的活化剂。在这项工作中,已经开发了一个新的HOCl探针平台,该平台整合了检测,成像和治疗功能。探针可以使用NIR发射和肉眼在体外检测HOCl,并且在超低浓度下具有高灵敏度和选择性(检测极限在纳摩尔水平)。基本水平的HOCl可以在HL-60细胞中成像,而无需特殊刺激。此外,此平台提供的探针可以在HOCl检测和成像过程中从前药中快速释放出含氨基或羧基的化合物,